ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.13
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,621.40
-0.93%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Hoth Therapeutics Inc (HOTH) Share Price

HOTH Hoth Therapeutics Inc

1.17
0.01 (0.86%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Hoth Therapeutics Inc NASDAQ:HOTH NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.01 0.86 1.17 1.16 1.50 1.22 1.16 1.19 31,982 04:00:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -7.85M -1.8049 -0.68 5.3M
 Type  Size  Price  Time  Units 
 9 83 1.15 23:28:43 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore HOTH News
14/05/202421:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/05/202413:00PRNUSHoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
27/03/202418:00PRNUSHoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
27/03/202412:27PRNUSHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
19/03/202412:21PRNUSHoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
29/02/202413:38PRNUSHoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
26/02/202413:11PRNUSHoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
Period
Draw mode
Data Downloads for HOTH

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Hoth Therapeutics Inc Articles